Form 4 for ANIX Anixa Biosciences Inc
Accepted 2023-07-21 00:00:00 ET · period of report 2023-07-20 · accession 0001493152-23-025185 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-21 | 2023-07-20 | ANIX | Catelani Michael | Pres, COO, CFO | P - Purchase | $3.64 | +5,500 | 26.7K | +26% | +$20.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-20 | P | A | 5,500 | $3.64 | 26,655 | D | — | — |